Eli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants.
Iovance Biotherapeutics, Inc. IOVA incurred a fourth-quarter 2024 loss of 26 cents per share, narrower than the Zacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback